Lemborexant

Spezifikationen

1369764-02-2CAS-Nummer

cis-(1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropane-1-carboxamideIUPAC-Name

C22H20F2N4O2Chemische Formel

410.4 g/molMolekulargewicht

Lemborexant; 1369764-02-2; Dayvigo; E-2006; E2006; 0K5743G68X; (1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide; Cyclopropanecarboxamide, 2-[[(2,4-dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)-, (1R,2S)-; DTXSID401027940; (1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide; (1R,2S)-2-[[(2,4-Dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropanecarboxamide; Cyclopropanecarboxamide, 2-(((2,4-dimethyl-5-pyrimidinyl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)-, (1R,2S)-; (1R,2S)-2-{[(2,4-dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide; (1R,2S)-2-(((2,4-dimethyl-5-pyrimidinyl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropanecarboxamide; (1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide; (1R,2S)-2-((2,4-DIMETHYLPYRIMIDIN-5-YL)OXYMETHYL)-2-(3-FLUOROPHENYL)-N-(5-FLUOROPYRIDIN-2-YL)CYCLOPROPANE-1-CARBOXAMIDE; lemborexantum; (1R,2S)-2-{[(2,4-dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide; RefChem:56887; DTXCID001513507; E 2006; (1~{R},2~{S})-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-~{N}-(5-fluoranylpyridin-2-yl)-2-(3-fluorophenyl)cyclopropane-1-carboxamide; Lemborexant [USAN:INN]; UNII-0K5743G68X; (1R,2S)-2-[[(2,4-Dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropanecarboxamide;; Dayvigo (TN); Lemborexant [INN]; Lemborexant(E2006); LEMBOREXANT [MI]; Lemborexant(E2006)?; Lemborexant; E-2006; LEMBOREXANT [JAN]; LEMBOREXANT [USAN]; orb14385; LEMBOREXANT [WHO-DD]; Lemborexant (JAN/USAN/INN); GTPL9302; SCHEMBL2116558; CHEMBL3545367; SCHEMBL29521503; LEMBOREXANT [ORANGE BOOK]; DEA NO. 2245; MUGXRYIUWFITCP-PGRDOPGGSA-N; GLXC-90502; EX-A2337; BDBM50093793; DB11951; compound 34 [PMID: 25953512]; NCGC00488783-01; NCGC00488783-02; NCGC00488783-03; AC-30918; FL103847; HY-16725; MS-27073; DB-145658; NS00073392; D11022; EN300-21614989; BRD-K78666663-001-01-6; Q20707990; (1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridyl)cyclopropanecarboxamide; 2482492-53-3; cis-(1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropane-1-carboxamideSynonyme